Arbor Capital Management (Minnesota)’s Emergent Biosolutions EBS Stock Holding History

Arbor Capital Management (Minnesota)’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$2.62M	Sell	93,000 -37,800	-29%	-$1.48M	1.38%	33
2016 Q1	$4.75M	Sell	130,800 -10,500	-7%	-$371K	1.49%	13
2015 Q4	$5.65M	Hold	141,300	–	–	1.28%	13
2015 Q3	$4.03M	Hold	141,300	–	–	0.89%	45
2015 Q2	$4.66M	Buy	+141,300	New	+$4.38M	0.88%	42

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arbor Capital Management (Minnesota)'s EBS Position: Q2 2016 in Review

Arbor Capital Management (Minnesota) reduced its Emergent Biosolutions (EBS) stake by 29% in Q2 2016, selling an estimated $1.48M and leaving 93,000 shares worth $2.62M. The position accounts for 1.38% of the portfolio, ranked #33.

Arbor Capital Management (Minnesota) first reported a position in EBS in Q2 2015 and has held it in 5 quarters since. The position peaked at $5.65M in Q4 2015. 224 funds tracked by Wall St. Rank hold EBS as of Q2 2016.

Arbor Capital Management (Minnesota) held 93,000 shares of Emergent Biosolutions worth $2.62M as of Q2 2016.
Arbor Capital Management (Minnesota) sold 37,800 Emergent Biosolutions shares in Q2 2016, an estimated $1.48M.
Emergent Biosolutions made up 1.38% of Arbor Capital Management (Minnesota)'s portfolio in Q2 2016, its #33 holding.
Arbor Capital Management (Minnesota) first reported a position in Emergent Biosolutions in Q2 2015 and has held it in 5 quarters since.
Arbor Capital Management (Minnesota)'s Emergent Biosolutions position peaked at $5.65M in Q4 2015.
224 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2016.

Based on Arbor Capital Management (Minnesota)'s 13F filing for Q2 2016, filed 15 Aug 2016.